The Association between Inflammation, Testosterone and SHBG in men: A cross‐sectional Multi‐Ethnic Study of Atherosclerosis
暂无分享,去创建一个
[1] U. Lindblad,et al. High C-reactive protein is associated with increased risk of biochemical hypogonadism: a population-based cohort study , 2022, Endocrine connections.
[2] B. Gower,et al. A Pilot Study of Associations Between Visceral Fat, IL-6, and Urinary F2-Isoprostanes in Older Adults Exposed to a Diet Intervention , 2021, Current developments in nutrition.
[3] R. Quinton,et al. Current National and International Guidelines for the Management of Male Hypogonadism: Helping Clinicians to Navigate Variation in Diagnostic Criteria and Treatment Recommendations , 2020, Endocrinology and metabolism.
[4] Wei Wang,et al. Sex hormone-binding globulin and arthritis: a Mendelian randomization study , 2020, Arthritis Research & Therapy.
[5] J. Toppari,et al. European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males , 2020, Andrology.
[6] B. Kestenbaum,et al. Association of Soluble TNFR-1 Concentrations with Long-Term Decline in Kidney Function: The Multi-Ethnic Study of Atherosclerosis. , 2018, Journal of the American Society of Nephrology : JASN.
[7] T. Asano,et al. Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome: In Vitro Evidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocytes and Macrophages , 2018, Mediators of inflammation.
[8] K. Peter,et al. Dissociation of C-Reactive Protein Localizes and Amplifies Inflammation: Evidence for a Direct Biological Role of C-Reactive Protein and Its Conformational Changes , 2018, Front. Immunol..
[9] Q. Lian,et al. Interleukin 6 inhibits the differentiation of rat stem Leydig cells , 2017, Molecular and Cellular Endocrinology.
[10] K. Watson,et al. Diabetes and Clinical and Subclinical CVD. , 2016, Global heart.
[11] J. Mulhall,et al. Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials. , 2016, The journal of sexual medicine.
[12] M. McCarthy,et al. Serum sex hormone-binding globulin and testosterone in relation to cardiovascular disease risk factors in young men: a population-based study. , 2014, European journal of endocrinology.
[13] Toshio Tanaka,et al. Interleukin 6 and Rheumatoid Arthritis , 2014, BioMed research international.
[14] R. Kronmal,et al. Relationship of CRP, IL-6, and fibrinogen with right ventricular structure and function: the MESA-Right Ventricle Study. , 2013, International journal of cardiology.
[15] A. Giwercman,et al. Negative Association between Testosterone Concentration and Inflammatory Markers in Young Men: A Nested Cross-Sectional Study , 2013, PloS one.
[16] R. Simó,et al. Potential Role of Tumor Necrosis Factor-α in Downregulating Sex Hormone–Binding Globulin , 2012, Diabetes.
[17] P. Dandona,et al. Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity. , 2011, The Journal of clinical endocrinology and metabolism.
[18] A. Araujo,et al. Association of sex hormones and C‐reactive protein levels in men , 2010, Clinical endocrinology.
[19] M. Criqui,et al. Sex hormones, sex hormone binding globulin, and abdominal aortic calcification in women and men in the multi-ethnic study of atherosclerosis (MESA). , 2008, Atherosclerosis.
[20] A. Silman,et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. , 2008, The Journal of clinical endocrinology and metabolism.
[21] Merlin C. Thomas,et al. Low testosterone levels are common and associated with insulin resistance in men with diabetes. , 2008, The Journal of clinical endocrinology and metabolism.
[22] G. Verleden,et al. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.
[23] P. Rosenstiel,et al. Soluble tumor necrosis factor (TNF) receptor‐1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor‐β1 , 2005 .
[24] W. Post,et al. Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). , 2004, American journal of hypertension.
[25] Christina Wang,et al. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. , 2004, The Journal of clinical endocrinology and metabolism.
[26] L. Niskanen,et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. , 2003, European journal of endocrinology.
[27] H. Watanobe,et al. Hypothalamic Interleukin-1β and Tumor Necrosis Factor-α, But Not Interleukin-6, Mediate the Endotoxin-Induced Suppression of the Reproductive Axis in Rats , 2003 .
[28] Edward T H Yeh,et al. Coming of age of C-reactive protein: using inflammation markers in cardiology. , 2003, Circulation.
[29] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[30] B E Ainsworth,et al. Compendium of physical activities: an update of activity codes and MET intensities. , 2000, Medicine and science in sports and exercise.
[31] D. Papanicolaou,et al. Dose-dependent effects of recombinant human interleukin-6 on the pituitary-testicular axis. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[32] R. Bergman,et al. Increased Insulin Resistance and Insulin Secretion in Nondiabetic African-Americans and Hispanics Compared With Non-Hispanic Whites: The Insulin Resistance Atherosclerosis Study , 1996, Diabetes.
[33] M. Cushman,et al. Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.
[34] S. Haffner,et al. Obesity, body fat distribution and sex hormones in men. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[35] P. Savage,et al. Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. , 1992, Journal of clinical epidemiology.
[36] L. Sjöström,et al. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. , 1990, Metabolism: clinical and experimental.
[37] Robert E. Jones,et al. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. , 1988, The Journal of clinical endocrinology and metabolism.
[38] J. Heaton. Hormone treatments and preventive strategies in the aging male: whom and when to treat? , 2003, Reviews in urology.
[39] J. Kaufman,et al. Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men. , 2003, Atherosclerosis.